16:01 Jan 19

Oxygenta Pharmaceutical Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
58.79
+3.77 (+6.85%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Oxygenta Pharmaceutical Ltd. Financials

Oxygenta Pharmaceutical Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
58.79
+3.77 (+6.85%)
16:01 Jan 19
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

11/100
Expensive Valuation

Technical

33/100
Technically Bearish

Strength

6

Weakness

7

Opportunity

0

Threats

0

-7.70 %

ROE %

-11.60 %

ROA %

0.00

EPS

-6.77

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
52.03 60.52 30.99 39.64 109.3
Operating Expenses +
48.18 59.06 38.1 49.34 119.29
Raw Material
43.02 42.67 28.13 35.06 100.23
Increase Decrease in Cost
-6.39 4.55 -4.63 -1.53 -3.76
Other Manufacturing Expense
5.67 5.45 11.73 7.44 11.16
Employee Cost
4.21 4.6 1.24 5.99 6.9
Miscellaneous Expenses
1.67 1.79 1.63 2.38 4.76
Operating Profit
3.85 1.46 -7.11 -9.7 -9.99
Other Income
0.09 0 0.02 0.04 1.31
Depreciation
1.2 1.59 2.05 2.66 0.82
Interest
1.78 0.92 1.49 1.59 1.78
Profit before tax and exceptio..
0.95 -1.04 -10.64 -13.91 -11.28
Exceptional Items
2.19 0.55 -0.73 0.04 -0.27
PBT
3.14 -0.49 -11.37 -13.87 -11.55
Provision for Taxation
0.21 0.12 0.2 -10.39 -1.87
Net Profit
2.93 -0.61 -11.57 -3.48 -9.68
NET Profit after MI
0 0 0 0 0
EPS
2.87 -0.48 -8.15 -1.09 -2.69
Operating Profit Margin (%)
7.4 2.41 -22.94 -24.47 -9.14
Net Profit Margin (%)
5.63 -1.01 -37.33 -8.78 -8.86

Oxygenta Pharmaceutical Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 55.90 58.00 58.00 51.10 51.10 53.30
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 44.10 42.00 42.00 48.90 48.90 46.70
Shareholder Shares Holding %
Download Our App On: